Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Name: Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Published: 2022
License: Public Domain

TolerogenixX GmbH · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

immunosuppression kidney-transplantation tolerance

kidney transplantation, living donor kidney transplantation, tol-2, modified immune cells, mic, mitomycin c, peripheral blood mononuclear cells, pbmc, kidney donor, tolerogenixx, tolerance, immunosuppression

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 844095
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.